Diabetic Foot Ulcers News

A Rare Cause of a Leg Ulcer in a Patient With Diabetes - Medscape



A Rare Cause of a Leg Ulcer in a Patient With Diabetes 
Medscape
Ulcers in patients with diabetes are common, affecting around 15% of patients at some stage of their disease. [1] Osteomyelitis complicates up to a third of such cases, and ulcer and foot complications result in more hospital admissions than any other ...

 


NeuroMetrix CEO Discusses Significance of WellMed Adoption of NC-stat(R ... - MarketWatch (press release)



NeuroMetrix CEO Discusses Significance of WellMed Adoption of NC-stat(R ... 
MarketWatch (press release)
The company is focused on nerve related complications of diabetes, called diabetic neuropathies, which affect over 50% of people with diabetes. If left untreated, diabetic neuropathies trigger foot ulcers that may require amputation, cause disabling ...

and more » 


Road show on diabetic foot ulcers starts today - Arab News



AME Info 
Road show on diabetic foot ulcers starts today 
Arab News
By JEDDAH: FOUZIA KHAN The Diabetic Foot Academy, a road show to draw attention to diabetic foot ulcers and all practical aspects of surgical treatment of diabetic foot ulcers, will start in Jeddah today and run until May 16. The initiative is taken by ...
Saudi Arabia's 'Diabetic Foot Academy' moves to the next level AME Info

all 2 news articles » 


Diabetes patients at risk from medication mistakes - The Guardian



Diabetes patients at risk from medication mistakes 
The Guardian
About 100 people with diabetes undergo leg, foot or toe amputations each week in England, many of which could be prevented, according to Diabetes UK. Foot ulcers are also common. Two-thirds of the patients included in the audit were admitted to ...

and more » 


Diabetes patients must take proper care of feet - SCNow



Diabetes patients must take proper care of feet 
SCNow
(more) Diabetic patients should schedule comprehensive diabetic foot exams to maintain the correct maintenance on their feet. Medicare pays for diabetic shoes and inserts which decrease chances for ulceration and subsequent amputation.

 


SANUWAVE Reports First Quarter Financial Results - MarketWatch (press release)



SANUWAVE Reports First Quarter Financial Results 
MarketWatch (press release)
Our focus remains the same, which is to achieve FDA approval as soon as possible in order to make dermaPACE available to the millions of US patients who suffer from debilitating, recalcitrant diabetic foot ulcers," concluded Mr. Cashman.

and more » 


Cardium Presents First Quarter 2012 Financial Results and Recent Developments - MarketWatch (press release)



Proactive Investors UK 
Cardium Presents First Quarter 2012 Financial Results and Recent Developments 
MarketWatch (press release)
Cardium received FDA 510(k) clearance for marketing and sales in the US of its Excellagen professional-use, sterile, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds in fourth quarter ...
Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen ... Healthcare Global (press release)
Angel Biotechnology's first collagen contract will earn it £400k a year from ... Scotsman

all 16 news articles » 


Cost Initiatives Bearing Fruit - Zacks.com



Cost Initiatives Bearing Fruit 
Zacks.com
As we've noted previously, the pivotal trial data already indicated dermaPACE was effective in healing diabetic foot ulcers - the hurdle to clear hitting the primary endpoint (100% wound closure), while not attained in the pivotal study, may very well ...

and more » 


SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for ... - MarketWatch (press release)



SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for ... 
MarketWatch (press release)
Christopher M. Cashman, President and CEO of SANUWAVE, said, "As previously reported, we believe that an IDE Supplement is the most appropriate course of action to support our PMA for dermaPACE in the treatment of diabetic foot ulcers.

and more » 


Derma Sciences Reports First Quarter 2012 Financial Results - MarketWatch (press release)



Derma Sciences Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
The TCC-EZ product is an important component of our strategy to be the leading supplier of products for the treatment of chronic wounds in general and diabetic foot ulcers in particular. To date, we have integrated the former head of the MedEfficiency ...

and more »